Ross, J. S., Wang, K., Gay, L. M., Al-Rohil, R. N., Nazeer, T., Sheehan, C. E., … Stephens, P. J. (2014). Next-Generation Sequencing (NGS) Reveals a High Frequency of IHC/FISH Negative Activating Extracellular Domain ERBB2 (HER2) Mutations in Micropapillary Urothelial Carcinoma That Can Respond to Anti-HER2 Targeting Agents. In MODERN PATHOLOGY (Vol. 27, pp. 256A-256A). San Diego, CA: NATURE PUBLISHING GROUP.

Ross, J. S., K. Wang, L. M. Gay, R. N. Al-Rohil, T. Nazeer, C. E. Sheehan, T. A. Jennings, et al. “Next-Generation Sequencing (NGS) Reveals a High Frequency of IHC/FISH Negative Activating Extracellular Domain ERBB2 (HER2) Mutations in Micropapillary Urothelial Carcinoma That Can Respond to Anti-HER2 Targeting Agents.” In MODERN PATHOLOGY, 27:256A-256A. NATURE PUBLISHING GROUP, 2014.

Ross JS, Wang K, Gay LM, Al-Rohil RN, Nazeer T, Sheehan CE, et al. Next-Generation Sequencing (NGS) Reveals a High Frequency of IHC/FISH Negative Activating Extracellular Domain ERBB2 (HER2) Mutations in Micropapillary Urothelial Carcinoma That Can Respond to Anti-HER2 Targeting Agents. In: MODERN PATHOLOGY. NATURE PUBLISHING GROUP; 2014. p. 256A-256A.

Ross, J. S., et al. “Next-Generation Sequencing (NGS) Reveals a High Frequency of IHC/FISH Negative Activating Extracellular Domain ERBB2 (HER2) Mutations in Micropapillary Urothelial Carcinoma That Can Respond to Anti-HER2 Targeting Agents.” MODERN PATHOLOGY, vol. 27, NATURE PUBLISHING GROUP, 2014, pp. 256A-256A.

Ross JS, Wang K, Gay LM, Al-Rohil RN, Nazeer T, Sheehan CE, Jennings TA, Otto GA, Donahue A, He J, Palmer G, Ali S, Nahas M, Young G, LaBrecque E, Frampton G, Erlich R, Curran JA, Brennan K, Downing SR, Yelensky R, Lipson D, Hawryluk M, Miller VA, Stephens PJ. Next-Generation Sequencing (NGS) Reveals a High Frequency of IHC/FISH Negative Activating Extracellular Domain ERBB2 (HER2) Mutations in Micropapillary Urothelial Carcinoma That Can Respond to Anti-HER2 Targeting Agents. MODERN PATHOLOGY. NATURE PUBLISHING GROUP; 2014. p. 256A-256A.